BlackRock’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152M Sell
6,735,343
-328,937
-5% -$7.31M ﹤0.01% 1840
2025
Q4
$183M Sell
7,064,280
-271,918
-4% -$6.47M ﹤0.01% 1740
2025
Q3
$189M Sell
7,336,198
-459,831
-6% -$11.3M ﹤0.01% 1693
2025
Q2
$186M Buy
7,796,029
+142,666
+2% +$3.6M ﹤0.01% 1657
2025
Q1
$190M Sell
7,653,363
-56,456
-0.7% -$1.35M ﹤0.01% 1622
2024
Q4
$145M Sell
7,709,819
-77,580
-1% -$1.36M ﹤0.01% 1851
2024
Q3
$117M Sell
7,787,399
-219,427
-3% -$3.75M ﹤0.01% 1993
2024
Q2
$229M Buy
8,006,826
+101,670
+1% +$2.89M 0.01% 1525
2024
Q1
$231M Sell
7,905,156
-209,095
-3% -$6.42M 0.01% 1554
2023
Q4
$274M Buy
8,114,251
+607,254
+8% +$17.8M 0.01% 1430
2023
Q3
$230M Buy
7,506,997
+25,528
+0.3% +$920K 0.01% 1436
2023
Q2
$300M Sell
7,481,469
-31,959
-0.4% -$1.32M 0.01% 1298
2023
Q1
$307M Buy
7,513,428
+261,983
+4% +$10.4M 0.01% 1247
2022
Q4
$280M Buy
7,251,445
+96,867
+1% +$4.71M 0.01% 1279
2022
Q3
$381M Buy
7,154,578
+43,517
+0.6% +$2.42M 0.01% 1003
2022
Q2
$415M Buy
7,111,061
+140,506
+2% +$9.2M 0.01% 984
2022
Q1
$532M Buy
6,970,555
+149,037
+2% +$9.93M 0.01% 928
2021
Q4
$410M Buy
6,821,518
+125,626
+2% +$6.93M 0.01% 1184
2021
Q3
$375M Buy
6,695,892
+36,812
+0.6% +$2.12M 0.01% 1221
2021
Q2
$404M Sell
6,659,080
-514,407
-7% -$32.6M 0.01% 1203
2021
Q1
$503M Buy
7,173,487
+73,640
+1% +$5.26M 0.01% 993
2020
Q4
$425M Buy
7,099,847
+438,448
+7% +$25.7M 0.01% 1018
2020
Q3
$400M Sell
6,661,399
-360,575
-5% -$21M 0.01% 881
2020
Q2
$368M Buy
7,021,974
+198,864
+3% +$8.31M 0.01% 907
2020
Q1
$229M Sell
6,823,110
-181,389
-3% -$7.54M 0.01% 1059
2019
Q4
$317M Buy
7,004,499
+245,550
+4% +$10.4M 0.01% 1143
2019
Q3
$257M Buy
6,758,949
+3,438,973
+104% +$137M 0.01% 1218
2019
Q2
$144M Buy
3,319,976
+3,374
+0.1% +$143K 0.01% 1664
2019
Q1
$126M Sell
3,316,602
-14,927
-0.4% -$583K 0.01% 1726
2018
Q4
$143M Buy
3,331,529
+45,072
+1% +$2.1M 0.01% 1562
2018
Q3
$162M Sell
3,286,457
-22,603
-0.7% -$977K 0.01% 1634
2018
Q2
$106M Buy
3,309,060
+81,149
+3% +$2.8M ﹤0.01% 1895
2018
Q1
$101M Sell
3,227,911
-64,486
-2% -$2.3M ﹤0.01% 1846
2017
Q4
$150M Sell
3,292,397
-28,496
-0.9% -$1.13M 0.01% 1588
2017
Q3
$125M Sell
3,320,893
-157,388
-5% -$6.33M 0.01% 1696
2017
Q2
$166M Buy
3,478,281
+294,494
+9% +$13.7M 0.01% 1440
2017
Q1
$145M Buy
3,183,787
+3,172,817
+28,923% +$137M 0.01% 1521
2016
Q4
$355K Sell
10,970
-16,353
-60% -$546K ﹤0.01% 1836
2016
Q3
$935K Buy
27,323
+23,316
+582% +$913K ﹤0.01% 1518
2016
Q2
$135K Buy
4,007
+1,510
+60% +$74.2K ﹤0.01% 2345
2016
Q1
$133K Buy
2,497
+1,376
+123% +$80.5K ﹤0.01% 1861
2015
Q4
$86K Buy
1,121
+287
+34% +$16.3K ﹤0.01% 1820
2015
Q3
$34K Sell
834
-124
-13% -$7.59K ﹤0.01% 2096
2015
Q2
$67K Sell
958
-61
-6% -$4.8K ﹤0.01% 1886
2015
Q1
$90K Hold
1,019
﹤0.01% 1802
2014
Q4
$90K Sell
1,019
-12,400
-92% -$1.17M ﹤0.01% 1763
2014
Q3
$1.3M Buy
13,419
+12,400
+1,217% +$1.21M ﹤0.01% 1156
2014
Q2
$94K Buy
1,019
+124
+14% +$9.44K ﹤0.01% 1735
2014
Q1
$62K Hold
895
﹤0.01% 1825
2013
Q4
$52K Hold
895
﹤0.01% 1917
2013
Q3
$43K Sell
895
-289
-24% -$10.5K ﹤0.01% 1899
2013
Q2
$34K Buy
+1,184
New +$34.3K ﹤0.01% 2023

Other funds holding PCRX